Molecular Formula: BeH₂O₄S
Molar mass: 107.090662 g/mol
EINECS: 236-842-2
Structure of Beryllium sulfate (1:1) (13510-49-1):

XLogP3-AA: 1.3
H-Bond Donor: 2
H-Bond Acceptor: 4
IUPAC Name: Beryllium; sulfuric acid
Canonical SMILES: [Be].OS(=O)(=O)O
InChI: InChI=1S/Be.H2O4S/c;1-5(2,3)4/h;(H2,1,2,3,4) 
InChIKey: ILZUVMDSMZZEPE-UHFFFAOYSA-N

NTP 10th Report on Carcinogens. IARC Cancer Review: Group 1 IMEMDT    IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 58 (1993),p. 41.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) ; Human Sufficient Evidence IMEMDT    IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 58 (1993),p. 41.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) ; Animal Sufficient Evidence IMEMDT    IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 1 (1972),p. 17.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) ; Animal Sufficient Evidence IMEMDT    IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 23 (1980),p. 143.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) ; Animal Sufficient Evidence IMEMDT    IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 58 (1993),p. 41.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) . Beryllium and its compounds are on the Community Right-To-Know List. Reported in EPA TSCA Inventory.

Confirmed carcinogen with experimental tumorigenic data. Acute poison by inhalation, ingestion, intraperitoneal, subcutaneous, intravenous, and intratracheal routes. See also BERYLLIUM COMPOUNDS and SULFATES. Mutation data reported. When heated to decomposition it emits very toxic fumes of SO_x and BeO.

OSHA PEL: TWA 0.002 mg(Be)/m³; STEL 0.005 mg(Be)/m³/30M; CL 0.025 mg(Be)/m³
ACGIH TLV: TWA 0.002 mg(Be)/m³; Confirmed Human Carcinogen; (Proposed: TWA 0.0002 mg(Be)/m³ (sensitizer); Confirmed Human Carcinogen)
NIOSH REL: (Beryllium) CL not to exceed 0.0005 mg(Be)/m³

 Beryllium sulfate (1:1) (13510-49-1) also can be called Sulfuric acid, beryllium salt (1:1) ; 1Beryllium sulfate (6CI,7CI)  ; Beryllium sulfate ;and Beryllium sulfate, BeSO₄ . Beryllium sulfate (1:1) (13510-49-1) is incompatible with the following: Acids, caustics, chlorinated hydrocarbons, oxidizers, molten lithium .Fire Hazard Special Hazards of Combustion Products: Toxic beryllium oxide and sulfuric acid fumes may form in fire.Any dramatic, unexplained weight loss should be considered as possible first indication of beryllium disease. Inhalation causes pneumonitis, nasopharyngitis, tracheobronchitis, dyspnea, chronic cough. Contact with eyes causes conjunctival inflammation.Contact with skin causes dermatitis of primary irritant or sensitization type; causes ulcer formation when in contact with cuts.